{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:37:06Z","timestamp":1790617026357,"version":"4.1.0"},"reference-count":25,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Rhabdomyolysis is a well-known clinical syndrome of muscle injury. Rhabdomyolysis following coronavirus disease 2019 (COVID-19) vaccination has recently been reported. The patients\u2019 weakness gradually subsided and did not recur. Rhabdomyolysis associated with COVID-19 vaccination has not been assessed by repeated magnetic resonance imaging (MRI) within a short time. We report a rare case of an older woman who developed recurring weakness with rhabdomyolysis after COVID-19 vaccination. A 76-year-old woman presented with myalgia 2 days after receiving a third dose of the COVID-19 vaccine. A physical examination showed weakness of the bilateral iliopsoas muscles. Her creatine kinase concentration was 9816 U\/L. MRI showed hyperintensity of multiple limb muscles. She was treated with intravenous normal saline. Her symptoms disappeared within 3 days. However, MRI on day 4 of hospitalization showed exacerbation of the hyperintensity in the left upper limb muscles. On day 5 of hospitalization, weakness of the left supraspinatus and deltoid muscles appeared. MRI on day 8 of hospitalization showed attenuation of the hyperintensity in all muscles. Her weakness and elevated creatine kinase concentration disappeared by day 10. Repeated MRI over a short time may be useful to predict potential weakness and monitor the course of COVID-19 vaccine-induced rhabdomyolysis.<\/jats:p>","DOI":"10.3390\/vaccines10060935","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T06:31:59Z","timestamp":1655101919000},"page":"935","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Recurring Weakness in Rhabdomyolysis Following Pfizer\u2013BioNTech Coronavirus Disease 2019 mRNA Vaccination"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7992-692X","authenticated-orcid":false,"given":"Motoya","family":"Kimura","sequence":"first","affiliation":[{"name":"Department of Neurology, Aichi Medical University, 1-1 Yazakokarimata, Nagakute 480-1195, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ichi","family":"Niwa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Aichi Medical University, 1-1 Yazakokarimata, Nagakute 480-1195, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Doyu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Aichi Medical University, 1-1 Yazakokarimata, Nagakute 480-1195, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1378\/chest.12-2016","article-title":"Rhabdomyolysis","volume":"144","author":"Zimmerman","year":"2013","journal-title":"Chest"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"101015","DOI":"10.1016\/j.disamonth.2020.101015","article-title":"Rhabdomyolysis","volume":"66","author":"Cabral","year":"2020","journal-title":"Dis Mon."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.tmaid.2012.11.004","article-title":"Rhabdomyolysis secondary to influenza A H1N1 vaccine resulting in acute kidney injury","volume":"11","author":"Callado","year":"2013","journal-title":"Travel. Med. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/20009666.2020.1841878","article-title":"Rhabdomyolysis after recombinant zoster vaccination: A rare adverse reaction","volume":"11","author":"Rajaratnam","year":"2021","journal-title":"J. Community Hosp. Intern. Med. Perspect."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/0091270010362537","article-title":"Rhabdomyolysis secondary to tetanus toxoid administration in a patient following minor laceration","volume":"51","author":"Hursitoglu","year":"2011","journal-title":"J. Clin. Pharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/jcph.145","article-title":"Causality of rhabdomyolysis and combined tetanus, diphtheria and acellular pertussis (Tdap) vaccine administration","volume":"53","author":"Kulkarni","year":"2013","journal-title":"J. Clin. Pharmacol."},{"key":"ref_7","first-page":"294","article-title":"Exertional Rhabdomyolysis after Military Training Paralleled by Systemic Microvascular Dysfunction and Plasma Cytokine Increase: A Case Report","volume":"113","author":"Pereira","year":"2019","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.jfma.2021.03.014","article-title":"Combined intravenous immunoglobulin and baricitinib treatment for severe COVID-19 with rhabdomyolysis: A Case report","volume":"120","author":"Wu","year":"2021","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_10","first-page":"002796","article-title":"Rhabdomyolysis Following Administration of Comirnaty\u00ae","volume":"8","author":"Elias","year":"2021","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"762006","DOI":"10.3389\/fimmu.2021.762006","article-title":"Case Report: ANCA-Associated Vasculitis Presenting with Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech COVID-19 mRNA Vaccination","volume":"12","author":"Hakroush","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"102170","DOI":"10.1016\/j.dsx.2021.06.007","article-title":"COVID-19 vaccine induced rhabdomyolysis: Case report with literature review","volume":"15","author":"Nassar","year":"2021","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_13","unstructured":"United States Department of Health and Human Services (DHHS), Public Health Service (PHS), Centers for Disease Control (CDC)\/Food and Drug Administration (FDA), and Vaccine Adverse Event Reporting System (VAERS) (2021, July 21). 1990\u20134\/16\/2021, CDC WONDER On-line Database, Available online: https:\/\/wonder.cdc.gov\/vaers.html."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1177\/0961203309345724","article-title":"Adjuvants and autoimmunity","volume":"18","author":"Israeli","year":"2009","journal-title":"Lupus"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13223-016-0114-4","article-title":"Post-vaccination myositis and myocarditis in a previously healthy male","volume":"12","author":"Cheng","year":"2016","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"ref_16","first-page":"e934399","article-title":"Myocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine: A Case Report","volume":"23","author":"Shukaili","year":"2022","journal-title":"Am. J. Case Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/qjmed\/hcab077","article-title":"Carnitine palmitoyltransferase II deficiency and post-COVID vaccination rhabdomyolysis","volume":"114","author":"Tan","year":"2021","journal-title":"QJM"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Gelbenegger, G., Cacioppo, F., Firbas, C., and Jilma, B. (2021). Rhabdomyolysis following Ad26.COV2.S COVID-19 Vaccination. Vaccines, 9.","DOI":"10.3390\/vaccines9090956"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-021-03791-x","article-title":"Systems Vaccinology of the BNT162b2 mRNA Vaccine in Humans","volume":"596","author":"Arunachalam","year":"2021","journal-title":"Nature"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.immuni.2020.07.019","article-title":"A Single Immunization with Nucleoside-Modified MRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice","volume":"53","author":"Hogan","year":"2020","journal-title":"Immunity"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1259\/0007-1285-62-736-326","article-title":"Acute rhabdomyolysis: Evaluation with magnetic resonance imaging compared with computed tomography and ultrasonography","volume":"62","author":"Lamminen","year":"1989","journal-title":"Br. J. Radiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1007\/s00415-021-10768-3","article-title":"COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis","volume":"269","author":"Faissner","year":"2022","journal-title":"J. Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ijid.2022.02.031","article-title":"Fatal thrombotic microangiopathy with rhabdomyolysis as an initial symptom after the first dose of mRNA-1273 vaccine: A Case Report","volume":"117","author":"Kamura","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/00004728-199309000-00023","article-title":"Repeat MRI in acute rhabdomyolysis: Correlation with clinicopathological findings","volume":"17","author":"Shintani","year":"1993","journal-title":"J. Comput. Assist. Tomogr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/01.rct.0000250115.10457.e9","article-title":"Rhabdomyolysis: Magnetic Resonance Imaging and Computed Tomography Findings","volume":"31","author":"Lu","year":"2007","journal-title":"J. Comput. Assist. Tomogr."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/6\/935\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:28:14Z","timestamp":1760138894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/6\/935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,11]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["vaccines10060935"],"URL":"https:\/\/doi.org\/10.3390\/vaccines10060935","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,11]]}}}